Low mortality of people living with diabetes mellitus diagnosed with COVID-19 and managed at a field hospital in Western Cape Province, South Africa

• Published in: South African medical journal Vol. 111; no. 10; pp. 961 - 967
• Main Authors: van der Westhuizen, J-N, Hussey, N, Zietsman, M, Saldulker, N, Manning, K, Dave, J A, Bulajic, B, Ras, T
• Format: Journal Article
• Language: English
• Published: South Africa Health and Medical Publishing Group (HMPG) 01-10-2021; Health & Medical Publishing Group
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Care and treatment; Complications and side effects; COVID-19 - epidemiology; COVID-19 - mortality; Cross-Sectional Studies; Diabetes; Diabetes Mellitus - epidemiology; Diabetes Mellitus - mortality; Female; Hospitalization - statistics & numerical data; Hospitals, Mobile; Humans; Male; Middle Aged; Mobile Health Units; Patient outcomes; Referral and Consultation - statistics & numerical data; Risk Factors; Services; South Africa - epidemiology; Telemedicine - statistics & numerical data; Young Adult; South Africa
• ISSN: 0256-9574; 2078-5135
• DOI: 10.7196/SAMJ.2021.v111i10.15779

Background. The novel coronavirus disease 2019 (COVID-19) was declared an international pandemic by the World Health Organization in March 2020. Throughout the pandemic, the association between diabetes mellitus (DM) and more severe COVID-19 has been well described internationally, with limited data, however, on South Africa (SA). The role of field hospitals in the management of patients with COVID-19 in SA has not yet been described.Objectives. To describe the mortality and morbidity of people living with DM (PLWD) and comorbid COVID-19, as well as to shed light on the role of intermediate facilities in managing DM and COVID-19 during the pandemic.Methods. This is a single-centre cross-sectional descriptive study that included all patients with confirmed COVID-19 and pre-existing or newly diagnosed DM (of any type) admitted to the Cape Town International Convention Centre (CTICC) Intermediate Care Bed Facility from June 2020 to August 2020. This study presents the profile of patients admitted to the CTICC, and reports on the clinical outcome of PLWD diagnosed with COVID-19, and additionally determines some associations between risk factors and death or escalation of care in this setting.Results. There were 1 447 admissions at the CTICC, with a total of 674 (46.6%) patients who had confirmed DM, of whom 125 (19%) were newly diagnosed diabetics and 550 (81%) had pre-existing DM. Included in this group were 57 referrals from the telemedicine platform – a platform that identified high-risk diabetic patients with COVID-19 in the community, and linked them directly to hospital inpatient care. Of the 674 PLWD admitted, 593 were discharged alive, 45 were escalated to tertiary hospital requiring advanced care and 36 died. PLWD who died were older, had more comorbidities (specifically chronic obstructive pulmonary disease, congestive cardiac failure and chronic kidney disease) and were more likely to be on insulin.Conclusions. In a resource-limited environment, interdisciplinary and interfacility collaboration ensured that complicated patients with DM and COVID-19 were successfully managed in a field hospital setting. Telemedicine offered a unique opportunity to identify high-risk patients in the community and link them to in-hospital monitoring and care. Future studies should explore ways to optimise this collaboration, as well as to explore possibilities for early identification and management of high-risk patients.